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Abstract: Introduction: It is unclear if children with a rhinovirus (RV)-induced wheezing exacerbation are more 
susceptible to viruses longitudinally, and whether a parental history of asthma and/or allergy impacts their susceptibility.  
The objective of this study was to determine if RV, RV-A and RV-C related wheezing exacerbations in children were 
associated with prior or subsequent viral detections and investigate the role of parental history of asthma and allergy.  
Materials and methods: Children presenting to hospital with acute wheeze were prospectively recruited and tested for 
respiratory viruses. Data on viruses detected in other respiratory samples (May 1997 to December 2012) were collected 
from hospital microbiology records and additional RV testing was performed on stored hospital respiratory samples 
(September 2009 to December 2012). A positive parental history was defined as either parent with self-reported asthma 
and/or allergy.  
Results: At recruitment, RV was detected in 69.2% of samples from children with an acute wheezing episode (n=373, 0–
16 years of age), with RV-C the most common virus (65.5%). Children with a history of parental asthma and/or allergy 
and RV at recruitment had a 14-fold increased incidence rate ratio (IRR) of subsequent RV detection (IRR 14.0, 95% CI 
1.9–104.1; p=0.01) compared with children without RV at recruitment. Children without this parental history had a 
reduced incident rate ratio for samples assessed during this time (IRR 0.5, 95% CI 0.3–0.9; p=0.03). 
Conclusion: Children with a parental history of asthma and/or allergy may become more susceptible to recurrent 
symptomatic RV infections.  
Keywords: Allergy, asthma, attack, childhood, respiratory virus, wheeze.  
1. INTRODUCTION 
Acute wheezing triggered by respiratory viral 
infections is a highly prevalent cause of hospital 
admission for children in developed countries [1-3]. 
Rhinovirus (RV) has been recognized as the main 
pathogen associated with these acute episodes [2-8], 
and possibly increases the risk of wheezing later on in 
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life in both non-hospitalized [9] and hospitalized 
children [10].  
Studies suggest that genetic predisposition to 
asthma and/or allergic disease may play a role in 
wheezing with RV and the respiratory outcome in 
children [11-13]. Infants with maternal disposition to 
atopic asthma were more likely to be infected with RV 
than respiratory syncytial virus (RSV) and suffered from 
more severe RV infection compared with infants 
without this disposition [11]. In a prospective birth 
cohort study including children predisposed to asthma 
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and/or allergy, RV was the most prevalent virus in 
recurrent moderate to severe wheezing episodes in 
infancy [12] and a similar study revealed that early-life 
RV wheezing illnesses were a strong predictor of 
wheezing and asthma at school age [13].  
In children and adults diagnosed with asthma, acute 
exacerbations are often associated with RV infections 
[7, 14-16]. Sensitization to common aeroallergens may 
be a risk factor for RV-related asthma exacerbations 
leading to paediatric hospital admissions [16] and 
allergic asthma has been associated with impaired 
components of the RV antiviral response, suggesting 
that children with allergic illness may have an 
increased susceptibility to RV [17].  
There are three species of RV; A (RV-A), B (RV-B) 
and C (RV-C) [6, 18]. We previously reported that RV-
C was the most common virus detected and associated 
with more severe wheezing exacerbations in children 
presenting to hospital compared with RV-A, RV-B and 
other viruses [2]. Furthermore, RV-C was associated 
with an increased risk of subsequent respiratory 
hospital admission particularly in atopic subjects [19]. 
However, there is a paucity of data on the recurrence 
of RV and RV species in children presenting to hospital 
with acute wheeze and the role of family predisposition 
to asthma and allergy. Although RV-C is often detected 
in children presenting to hospital with acute wheeze, it 
is unknown whether these children have an inherent 
susceptibility to this RV species 
The aim of this study was to determine the rate of 
viruses detected longitudinally in children who had 
presented to hospital with a RV-induced wheezing 
exacerbation.  
2. MATERIALS AND METHODS 
2.1. Study Subjects 
Children were enrolled from August 2002 to October 
2012 in the Perth Childhood Acute Asthma Study 
(PCAAS) and the Mechanisms of Acute Viral 
Respiratory Infections in Children (MAVRIC) study as 
previously described [2, 20]. Children aged 0–18 years 
were prospectively recruited when they presented with 
an acute wheezing episode to the Emergency 
Department (ED), Princess Margaret Hospital (PMH), 
Perth, Australia. Children were excluded if they had 
any other underlying chronic disorder, apart from 
asthma, or were born prematurely (< 36 weeks). All 
children (n=373) had data available on parental history 
of asthma and/or allergy and RV detection at 
recruitment. 
The PMH Human Ethics Committee approved the 
study and written informed consent was obtained from 
at least one parent/guardian for each subject.  
2.2. Data and Sample Collection 
2.2.1. Recruitment  
At recruitment, an ED physician determined each 
subject's diagnosis independent of the study including: 
acute asthma exacerbation, viral-induced wheeze, 
exercise-induced wheeze, wheeze with no specific 
trigger and other respiratory diagnoses. Exacerbation 
severity was scored according to a modified NIH score 
of clinical parameters as mild (0–2), moderate (3–6), or 
severe (7–10) [2, 21, 22]. A nasal specimen 
(nasopharyngeal aspirate (NPA), flocked swab or nasal 
wash) was obtained for testing of common respiratory 
viruses.  
History of parental asthma and/or allergy was 
defined as a positive response to the question “Does 
anyone in the family have asthma or allergy?” and an 
answer of “mother” or “father” to the question “What is 
their relationship to your child?” in a parent/guardian 
administered questionnaire. 
2.2.2. Respiratory Samples Assessed 
Longitudinally 
Data and samples other than recruitment were 
collected retrospectively as part of an audit from the 
PMH Department of Microbiology. Most of these 
samples were likely collected at other hospital 
presentations with a clinical indication for collection of a 
respiratory sample. Children were recorded as either 
positive or negative for each of the common respiratory 
viruses depending on the detection results of these 
samples. All samples collected and tested within seven 
days intervals were recorded as one sample. Data on 
respiratory samples (NPA, nose or throat swabs) were 
ascertained from May 1997 when the PMH Department 
of Microbiology records commenced through to 
December 2012. Where available, samples stored 
between September 2009 and December 2012 (3.2 
years) by the PMH Department of Microbiology 
underwent further RV testing and typing in our research 
laboratory. 
2.2.3. Respiratory Virus Detection at Recruitment 
and Longitudinally  
Respiratory samples were routinely tested by the 
PMH Department of Microbiology for the presence of 
RSV, adenovirus, influenza virus A and B, 
parainfluenza virus 1, 2 and 3, as well as human 
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metapneumovirus using immunofluorescence, virus 
culture, or polymerase chain reaction (PCR). RV was 
tested on an ad hoc basis using semi-nested reverse 
transcription (RT)-PCR by PathWest Laboratory 
Medicine, Perth, WA, Australia [23].  
In our laboratory, RV was examined in respiratory 
samples collected at recruitment and retrieved from the 
PMH Department of microbiology, using a two-step 
PCR amplification of the RV 5’ non-coding region as 
previously described [2, 6, 24]. If positive, PCR 
products were DNA sequenced and RV species were 
determined by alignment with the RV sequence of 101 
classical serotypes and the 53 recently identified types 
using phylogenetic tree reconstruction with Clustal X 
Software. The species assignment of these new types 
was previously confirmed by analysing the 420-bp 
VP4-VP2 sequences of the coding region of 
representative samples of each type [20, 25]. Further 
genetic analyses of all RV positive samples were done 
to make sure that each illness represented a new 
infection.  
2.3. Statistical Analyses 
Respiratory samples assessed before and after 
recruitment as well as children with and without a 
parental history of asthma and/or allergy, were 
analysed separately. 
Within each group, children with RV, RV-A and  
RV-C were compared with those that had another virus 
or no virus detected at recruitment. Separate analyses 
were not performed on children with RV-B at 
recruitment due to the small numbers of children with 
this species. Co-infections were recorded separately; 
hence children with both RV and another virus at 
recruitment or at other hospital attendances were 
analysed as separate viral detections.  
We used STATA version 13 and a Poisson 
regression model to determine the incidence rate ratio 
(IRR). The IRR compared the mean number of 
respiratory samples assessed and viruses detected 
(RV-A, RV-B, RV-C and other viruses (RSV, 
adenovirus, influenza virus A and B, parainfluenza 1, 2 
and 3, and human metapneumovirus) during a study 
period (before and after recruitment) between 
recruitment samples with and without RV, RV-A or  
RV-C.  
Models were adjusted for age, gender and 
observation period, to adjust for different length of 
follow up for each child according to recruitment time.  
3. RESULTS 
3.1. Study Population 
Children with a wheezing exacerbation at 
recruitment (n=373) had a mean age of 4.5 years 
(standard deviation [SD] = 3.3, range 0.1–15.6) and 
were mostly male (60.1%) (Table 1). The majority of 
children with acute wheeze had a moderate severity 
score (65.0%) and a parental history of asthma and/or 
allergy (61.9%). Of children with a genetic 
predisposition to asthma and/or allergy, most children 
had only one parent with asthma and/or allergy 
(78.4%), which was primarily maternal (53.0%)  
(Table 2). 
Table 1: Study Population Demographics 
Study subjects, n 373 † 
Gender male, n (%) 224 (60.1) 
Age at recruitment in years, mean ± SD 
(range) 4.5 ± 3.3(0.1-15.6) 
Season recruited, n (%)  
 Spring  87 (23.3) 
 Summer  26 (7.0) 
 Fall  79 (21.2) 
 Winter  181 (48.5) 
† If not otherwise stated. 
 
Table 2: Clinical Data on Study Population at 
Recruitment 
Diagnosis at recruitment, n (%) 309 (100) 
 Acute asthma exacerbation 177 (57.3) 
 Viral induced wheeze 75 (24.3) 
 Wheeze, exercise-induced or no 
specific trigger 7 (2.3) 
 Other respiratory diagnosis 50 (16.2) 
Acute asthma severity score, n (%) 300 (100) 
 Mild (0–2)  35 (11.7) 
 Moderate (3–6)  195 (65.0) 
 Severe (7–10)  70 (23.3) 
Parental history of asthma and/or allergy, n (%) 231 (61.9) 
Uniparental 181 (78.4) 
 Mother 96 (53.0) 
 Father 85 (47.0) 
Biparental 50 (21.6) 
3.2. Respiratory Viruses Detected at Recruitment 
A respiratory virus was detected in 79.9% of 
children recruited with a wheezing exacerbation (n=298 
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virus detected/373 children tested). The majority of 
cases had RV (69.2%, n=258/373) (Figure 1), either as 
a single detection (61.1%, n=228/373) or co-detected 
with another respiratory virus (8.0%, n=30/373). A 
different respiratory virus was detected in 10.7% of 
children (n=40/373) of which RSV was the most 
common (7.8%, n=29/373). Of the 258 RV-positive 
respiratory specimens, all were successfully typed. The 
most common species was RV-C (65.5%, n=169/258), 
with RV-A and RV-B detected in 32.9% (n=85/258) and 
2.3% (n=6/258), respectively. Dual detection of RV-A 
and RV-C occurred in two samples (recorded 
separately).  
 
Figure 1: Percentage of RV species detected at recruitment 
n=298 viruses detected (373 children tested); two subjects 
had RV-A and C co-infection. 
3.3. Respiratory Samples Assessed Longitudinally 
Data from respiratory virus assessments completed 
by the PMH Department of Microbiology between May 
1997 and December 2012 were used to determine the 
rate of respiratory viruses in these 373 children. The 
mean study duration of data collected before and after 
these children were recruited was 4.1 (SD 2.7) and 4.0 
years (SD 3.0), respectively, and the mean age at the 
end of the study period was 8.4 years (SD 5.4)  
(Table 3). Subjects had a higher mean number of 
respiratory samples assessed before than after 
recruitment (0.7 [SD 1.5] vs. 0.3 [SD 0.8], respectively). 
There was a correlation between age at recruitment 
and the mean number of respiratory samples assessed 
before (β-coefficient = 0.6, 95% confidence interval 
(95% CI) 0.4–0.9; p<0.001) and after recruitment  
(β-coefficient = 0.5, 95% CI 0.3–0.6; p<0.001). For 
samples potentially available from the PMH 
Department of Microbiology over the previous 3.2 years 
(September 2009-December 2012), 64.1% samples 
were located (n=109 retrieved/170 potentially available 
respiratory samples) and most were collected after 
recruitment (59.6%, n=65/109). The proportion of 
samples tested for RV was therefore lower before 
recruitment (28.0%, n=77 RV tested/275 respiratory 
samples assessed) than after recruitment (59.3%, 
n=73/123). 
3.4. Respiratory Viruses Detected Longitudinally  
RV was the most common virus detected in virus-
positive samples both before (55.0%, n=60 RV 
detected/109 virus positive samples) and after (71.0%, 
n=49/69) recruitment (Figure 2). Of the RV-positive 
samples, 58.3% (n=35 typed/60 HRV positive) 
 
Figure 2: Percentage of viruses detected longitudinally. Numbers above columns refer to number of viruses detected; shaded 
columns: viruses detected before recruitment from n (respiratory samples) = 275; solid columns: viruses detected after 
recruitment from n (respiratory samples) = 123; other viruses: respiratory syncytial virus, adenovirus, influenza virus A and B, 
parainfluenza 1,2 and 3, human metapneumovirus; RV (Rhinovirus). 
Table 3: Follow-up Data 
Age at end of follow up time in years, 
mean ± SD (range) 8.4 ± 5.4 (0.4–23.9) 
Follow-up time before recruitment in years, 
mean ± SD (range) 4.1 ± 2.7 (0.1–3.0) 
Follow-up time after recruitment in years, 
mean ± SD (range) 4.0 ± 3.0 (0.2–0.3) 
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assessed before and 83.7% (n=41/49) assessed after 
recruitment, were typed. RV-C was detected in the 
majority of typed samples both before (62.9%, n=22 
RV-C/35 typed) and after recruitment (73.2%, 
n=30/41). RV-A was the next most common species, 
identified in 31.4% (n=11 RV-A/35 typed) of samples 
before and in 22.0% (n=9/41) of samples after 
recruitment.  
3.5. Incidence Rate Ratio of Respiratory Sample 
Assessment and Viral Detection Longitudinally 
3.5.1. Recurrent Sampling and Viral Detection 
before Recruitment 
There was a trend towards an increased IRR for 
prior RV detection in children with a parental history of 
asthma and/or allergy who had RV at recruitment 
compared with children with no RV detected at 
recruitment (IRR 2.3, 95% CI 0.9–5.8; p=0.09). For all 
other analyses of children with and without parental 
asthma and/or allergy, there were no differences in the 
mean number of respiratory samples assessed or 
viruses detected before recruitment between children 
with and without RV, RV-A or RV-C at recruitment. 
3.5.2. Recurrent Sampling and Viral Detection after 
Recruitment 
Children with no parental history of asthma and/or 
allergy that had RV detected at recruitment had a lower 
rate of respiratory samples assessed (IRR 0.5, 95%  
CI 0.3–0.9; p=0.03) and a trend towards a lower 
incidence of other viruses detected (IRR 0.1, 95% CI 
0.01–1.3; p=0.09) after recruitment than children 
without RV at recruitment (Figure 3). 
In the group of children with a parental history of 
asthma and/or allergy, subjects with RV at recruitment 
had a higher incidence of respiratory samples 
assessed (IRR 3.0, 95% CI 1.6–5.7; p=0.001) and a 
14-fold increase in IRR for recurrent RV (IRR 14.0, 
95% CI 1.9–104.1; p=0.01) relative to children without 
RV at recruitment. In addition, there was a trend 
towards a six-fold increase in IRR for detection of other 
viruses (IRR 6.6, 95% CI 0.9–50.3; p=0.07). 
Furthermore, children in this high-risk group that 
had a RV-C wheezing exacerbation at recruitment had 
a trend towards more recurrent RV-C detections (IRR 
3.2, 95% CI 0.9–11.4; p=0.07) following recruitment 
than children without RV-C at recruitment. 
There were no other associations between RV,  
RV-A or RV-C detected at recruitment and samples 
assessed or viruses detected after recruitment. 
4. DISCUSSION 
This study revealed that children with a genetic 
predisposition to asthma and/or allergy that presented 
 
Figure 3: Incidence rate ratio for samples assessed and virus detection longitudinally, after recruitment. n study subjects = 373; 
∆ p < 0.1; * p < 0.05; ÷ result not presented in figure due to value = 0; this result is non-significant); other viruses: respiratory 
syncytial virus, adenovirus, influenza virus A and B, parainfluenza 1, 2 and 3, human metapneumovirus; RV (Rhinovirus). 
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to hospital with RV-related wheezing were more likely 
to have subsequent viral testing and detection of RV 
than children without this predisposition. 
To our knowledge, this is the first study to report the 
relationship between RV and RV species in children 
attending hospital with acute wheeze and repeated 
childhood RV detection and furthermore, to suggest 
that genetic predisposition may play a critical role in a 
child's propensity to develop severe recurrent viral 
infections. 
We previously showed that RV-C is associated with 
the majority and most severe acute wheezing episodes 
in children presenting to hospital [2]. RV-C was also 
associated with subsequent respiratory hospital 
admissions [19] and this study found limited evidence 
of increased recurrent detection of RV-C in children 
who had attended hospital-based care. These findings 
suggest that children with a genetic predisposition to 
asthma and/or allergic disease and an RV-C related 
wheezing exacerbation could be more susceptible to 
further RV-C and that this RV species may induce 
more severe respiratory illnesses. It is most likely that 
an illness that necessitated sample collection and 
testing for respiratory viruses was more severe, thus 
viral detection is likely to have occurred as a result of a 
symptomatic infection. However, we cannot preclude 
that episodes of RV illness occurred at other times in 
hospital or the community but were of insufficient 
severity to prompt sample collection and thereby be 
recorded in this study. 
The PMH Department of Microbiology does not 
routinely investigate respiratory samples for RV or RV 
strain. We retrieved most samples stored by the PMH 
Department of Microbiology over the previous three 
years from 2012. However lack of availability of further 
samples and missing results may contribute to the 
limited evidence of RV species-specific recurrence 
after recruitment and may also have masked 
association between RV or RV species detected at 
recruitment and an increased rate of viral detection 
before recruitment. The possibility that children at high 
risk for asthma and/or allergy are more susceptible to 
RV overall, can therefore not be precluded. Our 
findings suggest that increased routine testing for RV in 
children at high risk of asthma and/or allergic disease 
presenting to hospital with respiratory illnesses may 
repeatedly detect RV and thus identify children at high 
risk of developing recurrent wheezing exacerbations. 
The association between RV detection and further 
respiratory illnesses in children genetically at high risk 
for developing allergic respiratory diseases has 
previously been reported [12, 13, 26-28]. Community-
based cohort studies of children with parental history of 
atopy have demonstrated that early life aeroallergen 
sensitization predisposes children to subsequent RV-
related wheezing illnesses [26] and wheezing with RV 
during infancy was associated with the subsequent 
development of asthma at age 5 in sensitized children 
[13]. Similar studies revealed that RV-induced 
wheezing episode in the first year of life was a 
significant risk factor for wheezing at 3 years of age, 
[27] and an increasing frequency of RV-related 
wheezing illnesses during the first 3 years of life was 
associated with development of asthma at age 6 [28], 
suggesting RV recurrence may impact asthma 
development. 
Samples for the present study were collected from 
children in a hospital setting, suggesting more severe 
respiratory illnesses compared with the previously 
described cohorts. Furthermore, separate analyses 
were performed on children with and without a genetic 
predisposition to asthma and/or allergic disease, 
identifying a difference within the high-risk group but 
not the low risk group for several parameters 
investigated. To our knowledge, previous studies have 
not been able to distinguish the role of atopy on 
wheeze and RV infections since their recruitment was 
limited to children only at high-risk of atopy and 
asthma. The results of this study indicate that a 
parental history of asthma and/or allergy may be a 
critical factor in severe recurrent RV-induced wheezing 
illnesses in children. A limitation of the present study 
was the lack of clinical information associated with the 
assessment of respiratory samples; hence it remains 
unknown whether RV detections in samples collected 
at other times were associated with wheezing. RV can 
be detected in children without respiratory symptoms, 
implying that presence of RV does not always reflect 
symptomatic infection. However, samples in this study 
were collected in a hospital setting most likely as a 
result of more severe infection as they would prompt 
more comprehensive testing. 
In a study of 7–12-year-old children with asthma, 
increasing levels of serum allergen-specific 
Immunoglobulin E (IgE) antibody were associated with 
a substantial increase in the probability of RV-related 
wheeze, indicating that atopy plays a role in modifying 
the host anti-viral responses, [29] consistent with our 
findings. Our analyses used parental history of asthma 
and/or allergy as a surrogate because children with this 
family history have an increased likelihood of 
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developing these conditions [30] independent of their 
age at the time of study. Thus we avoided potential 
misclassification of some children as non-atopic since 
their recruitment at a young age may have preceded 
their development of skin prick test positivity. 
Studies on the association between allergic 
respiratory illnesses and RV detection rates in children 
are limited. Nasal samples collected from asthmatic 
children during five consecutive weeks for at least one 
RV peak season did not indicate that children with 
atopic asthma were more prone to have RV detected 
than non-atopic asthmatic children, although atopic 
asthmatics did experience more symptomatic infections 
[31]. Since we focused on children presenting to 
hospital with a wheezing exacerbation rather than 
children with asthma in the community, the differences 
in these study designs possibly influenced their 
findings. Moreover, our study was strengthened by 
several factors: a longer study period after recruitment 
(4.0 years versus 3 years), sample collection not 
subject to the systematic bias caused by subjects lost 
to follow-up (in the study by Olenec. et al. most 
participants completed only one season during the 3 
year study time), a greater number of participants  
(373 versus 42 children) [31] and minimising selection 
bias for those children with known asthma and/or 
allergy being more likely to seek care in a prospectively 
study design. 
This study included data from 1997 when the PMH 
Department of Microbiology records commenced, thus, 
older children recruited at the beginning of the study 
may have had respiratory samples collected and tested 
for viruses before this date. Also, the follow-up time 
both before and after recruitment varied according to 
when a child was enrolled in the study. We adjusted for 
the variations in longitudinal analyses by including the 
duration of follow-up for each participant before and 
after recruitment in the statistical analyses.  
Previous studies have shown that RV is an 
important pathogen in children at high-risk of asthma 
and/or allergy [11-13, 17, 26-28] and our findings 
suggest that such predispositions may underpin the 
relationship between RV and recurrent viral infections. 
There is evidence that asthmatics with an atopic 
tendency have altered immune responses to RV 
infection [17]. We postulate that this altered antiviral 
response predisposes children to repeated viral 
infections, particularly with RV, that results in 
symptoms severe enough to warrant medical attention. 
Whether RV infections induce or are a consequence of 
immunological changes requires further study. We 
have found that species-specific RV-C antibodies are 
low in children infected with RV regardless of asthmatic 
status [32], suggesting a less efficacious antiviral 
immune response to this species. However, further 
assessment of RV-specific antibody responses will help 
determine if there are differences in protection following 
RV infection between children with and without atopy.  
CONCLUSION 
Children predisposed to asthma and/or allergy with 
an RV wheezing exacerbation may be prone to 
recurrent RV detection whereas children without this 
predisposition do not. These findings may improve our 
ability to identify children at heightened risk of recurrent 
infections and illnesses. 
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